News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
217,468 Results
Type
Article (35639)
Company Profile (16)
Press Release (181813)
Section
Business (65392)
Career Advice (471)
Deals (6019)
Drug Delivery (27)
Drug Development (28859)
Employer Resources (52)
FDA (4706)
Job Trends (4545)
News (103803)
Policy (6989)
Tag
2024 Biotech Bay Standard (2)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
Academia (2448)
Academic (1)
Accelerated approval (1)
Adcomms (9)
Allergies (26)
Alliances (14431)
ALS (25)
Alzheimer's disease (609)
Antibody-drug conjugate (ADC) (28)
Approvals (4733)
Artificial intelligence (55)
Autoimmune disease (3)
Automation (4)
Bankruptcy (62)
Best Places to Work (3720)
BIOSECURE Act (11)
Biosimilars (32)
Biotechnology (16)
Bladder cancer (25)
Brain cancer (11)
Breast cancer (85)
Cancer (664)
Cardiovascular disease (47)
Career advice (429)
Career pathing (11)
CAR-T (67)
Cell therapy (149)
Cervical cancer (6)
Clinical research (22547)
Collaboration (184)
Compensation (16)
Complete response letters (2)
COVID-19 (1433)
CRISPR (14)
C-suite (135)
Cystic fibrosis (31)
Data (738)
Decentralized trials (1)
Denatured (3)
Depression (15)
Diabetes (56)
Diagnostics (2066)
Digital health (1)
Diversity (5)
Diversity, equity & inclusion (18)
Drug discovery (28)
Drug pricing (46)
Drug shortages (1)
Duchenne muscular dystrophy (22)
Earnings (11023)
Editorial (9)
Employer branding (8)
Employer resources (47)
Events (24424)
Executive appointments (447)
FDA (4999)
Featured Employer (4)
Frontotemporal dementia (4)
Funding (227)
Gene editing (35)
Generative AI (3)
Gene therapy (74)
GLP-1 (179)
Government (1317)
Guidances (5)
Healthcare (6327)
Huntington's disease (2)
IgA nephropathy (6)
Immunology and inflammation (28)
Indications (12)
Infectious disease (1473)
Inflammatory bowel disease (51)
Inflation Reduction Act (4)
Influenza (17)
Intellectual property (16)
Interviews (59)
IPO (2333)
IRA (29)
Job creations (944)
Job search strategy (401)
Kidney cancer (5)
Labor market (8)
Layoffs (83)
Leadership (2)
Legal (1671)
Liver cancer (22)
Lung cancer (102)
Lymphoma (45)
Machine learning (1)
Management (15)
Manufacturing (59)
MASH (20)
Medical device (4020)
Medtech (4021)
Mergers & acquisitions (3717)
Metabolic disorders (135)
Multiple sclerosis (19)
NASH (6)
Neurodegenerative disease (26)
Neuropsychiatric disorders (8)
Neuroscience (764)
NextGen: Class of 2025 (2299)
Non-profit (2082)
Northern California (641)
Now hiring (3)
Obesity (58)
Opinion (69)
Ovarian cancer (30)
Pain (16)
Pancreatic cancer (26)
Parkinson's disease (51)
Partnered (4)
Patents (46)
Patient recruitment (31)
Peanut (16)
People (36122)
Pharmaceutical (2)
Pharmacy benefit managers (6)
Phase I (6937)
Phase II (9921)
Phase III (7442)
Pipeline (215)
Podcasts (10)
Policy (57)
Postmarket research (1208)
Preclinical (3391)
Press Release (27)
Prostate cancer (32)
Psychedelics (13)
Radiopharmaceuticals (80)
Rare diseases (108)
Real estate (1677)
Recruiting (22)
Regulatory (4538)
Reports (6)
Research institute (1475)
Resumes & cover letters (34)
Rett syndrome (1)
RNA editing (1)
RSV (2)
Schizophrenia (17)
Series A (37)
Series B (22)
Service/supplier (1)
Sickle cell disease (17)
Southern California (539)
Special edition (6)
Spinal muscular atrophy (47)
Sponsored (7)
Startups (1466)
Stomach cancer (1)
Supply chain (5)
The Weekly (7)
United States (5455)
Vaccines (284)
Venture capitalists (5)
Webinars (10)
Weight loss (36)
Women's health (10)
Worklife (2)
Date
Today (35)
Last 7 days (168)
Last 30 days (747)
Last 365 days (9234)
2025 (1877)
2024 (9648)
2023 (11750)
2022 (16321)
2021 (17370)
2020 (16738)
2019 (15659)
2018 (11730)
2017 (10943)
2016 (10895)
2015 (12686)
2014 (9432)
2013 (9056)
2012 (9101)
2011 (9180)
2010 (8312)
Location
Africa (317)
Alabama (15)
Alaska (3)
Arizona (49)
Arkansas (6)
Asia (12046)
Australia (3040)
California (1411)
Canada (457)
China (111)
Colorado (63)
Connecticut (83)
Delaware (33)
Europe (32713)
Florida (186)
Georgia (62)
Idaho (17)
Illinois (140)
India (6)
Indiana (69)
Iowa (3)
Japan (45)
Kansas (16)
Kentucky (6)
Maine (16)
Maryland (181)
Massachusetts (944)
Michigan (56)
Minnesota (84)
Mississippi (2)
Missouri (18)
Montana (6)
Nebraska (9)
Nevada (10)
New Hampshire (27)
New Jersey (472)
New Mexico (9)
New York (399)
North Carolina (313)
North Dakota (2)
Northern California (641)
Ohio (71)
Oklahoma (5)
Oregon (10)
Pennsylvania (297)
Puerto Rico (1)
Rhode Island (8)
South America (363)
South Carolina (4)
Southern California (539)
Tennessee (39)
Texas (232)
Utah (45)
Virginia (34)
Washington D.C. (26)
Washington State (142)
West Virginia (1)
Wisconsin (10)
217,468 Results for "johns hopkins university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Partnered
From Theory to Practice: Johns Hopkins Design Team Sets Undergrads Up for Success
At Johns Hopkins University, the biomedical engineering program’s Design Team offering lets undergraduates dive deep into clinical projects that can help them land industry jobs, get provisional patents or even start companies.
November 6, 2024
·
6 min read
·
BioSpace Insights
Press Releases
Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University
March 7, 2025
·
4 min read
Business
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
Danaher Corporation, a global science and technology innovator, launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI.
May 9, 2024
·
6 min read
Press Releases
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
TriLink BioTechnologies, a Maravai™ LifeSciences company and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery.
May 13, 2024
·
3 min read
Press Releases
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
January 23, 2025
·
8 min read
BioCapital
Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University
Inhibitor Therapeutics, Inc. has entered into an exclusive, worldwide licensing agreement with Johns Hopkins University for their U.S Patent 8,980,930 “New Angiogenesis Inhibitors”.
December 13, 2023
·
5 min read
Biotech Beach
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
Exagen Inc., a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced the execution of an exclusive license agreement.
November 9, 2023
·
3 min read
Business
Allosteric Bioscience, Inc. Signs Sponsored Research Agreement with Dr. Susan Michaelis at Johns Hopkins University for Aging/Longevity-Related Work
Allosteric Bioscience, Inc. (ABI) has signed a Sponsored Research Agreement (SRA) with Dr. Susan Michaelis at Johns Hopkins University for analysis of chemical leads for modulation (increase or decrease) of key protein targets for Optimizing Aging and Longevity.
January 17, 2024
·
3 min read
Press Releases
PharmAla to supply Johns Hopkins Medicine for Clinical Trial
September 11, 2024
·
4 min read
Business
Histogen Announces Exclusive Intellectual Property License Agreement with Johns Hopkins University
Histogen Inc. (HSTO) today announced that the company has signed an exclusive license agreement with Johns Hopkins University.
April 3, 2023
·
6 min read
1 of 21,747
Next
